Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
AMGEN INC (AMGN)
Busch Matthew C. — VP, Finance & CAO
Shares
1,000
Price
$375.79
Total Value
$375.79K
Shares Held After
3,423
% of Holdings
22.6%
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
8,143
Price
$59.05
Total Value
$480.84K
Shares Held After
99,447
% of Holdings
7.6%
Tempus AI, Inc. (TEM)
Bartolucci Ryan M — Chief Accounting Officer
Shares
2,902
Price
$59.05
Total Value
$171.36K
Shares Held After
41,159
% of Holdings
6.6%
Tempus AI, Inc. (TEM)
Rogers James William — Chief Financial Officer
Shares
10,084
Price
$59.05
Total Value
$595.46K
Shares Held After
101,166
% of Holdings
9.1%
ENSIGN GROUP, INC (ENSG)
Uychiat Pison Marivic — Director
Shares
83
Price
$211.02
Total Value
$17.51K
Shares Held After
14,407
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
4,422
Price
$17.57
Total Value
$77.69K
Shares Held After
15,080
% of Holdings
29.3%
Tempus AI, Inc. (TEM)
Phelps Erik — EVP, Chief Admin. Officer
Shares
5,650
Price
$59.05
Total Value
$333.63K
Shares Held After
79,816
% of Holdings
6.6%
Tempus AI, Inc. (TEM)
Phelps Erik — EVP, Chief Admin. Officer
Shares
3,814
Price
$60.00
Total Value
$228.84K
Shares Held After
85,466
% of Holdings
4.3%
Tempus AI, Inc. (TEM)
Fukushima Ryan — Chief Executive Officer, Data
Shares
9,592
Price
$59.05
Total Value
$566.41K
Shares Held After
694,354
% of Holdings
1.4%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
2,112
Price
$52.58
Total Value
$111.05K
Shares Held After
85,115
% of Holdings
2.4%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
6,967
Price
$52.58
Total Value
$366.32K
Shares Held After
226,106
% of Holdings
3.0%
DANAHER CORP /DE/ (DHR)
Milosevich Gregory M — Executive Vice President
Shares
1,320
Price
$208.01
Total Value
$274.57K
Shares Held After
5,099
% of Holdings
20.6%
ENSIGN GROUP, INC (ENSG)
Wittekind Beverly B. — VP and Chief Legal Officer
Shares
500
Price
$210.23
Total Value
$105.11K
Shares Held After
32,779
% of Holdings
1.5%
QUEST DIAGNOSTICS INC (DGX)
Plewman Patrick — SVP for Diagnostic Services
Shares
958
Price
$204.83
Total Value
$196.23K
Shares Held After
15,838
% of Holdings
5.7%
QUEST DIAGNOSTICS INC (DGX)
PREVOZNIK MICHAEL E — SVP & General Counsel
Shares
1,111
Price
$204.83
Total Value
$227.57K
Shares Held After
38,371
% of Holdings
2.8%
QUEST DIAGNOSTICS INC (DGX)
Doherty Catherine T. — EVP, Regional Businesses
Shares
1,433
Price
$204.83
Total Value
$293.52K
Shares Held After
68,402
% of Holdings
2.1%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
15,540
Price
$12.30
Total Value
$191.16K
Shares Held After
270,432
% of Holdings
5.7%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
100
Price
$16.00
Total Value
$1.60K
Shares Held After
156,052
% of Holdings
0.1%
ACCURAY INC (ARAY)
MAYER STEVEN F — Director
Shares
69,000
Price
$0.53
Total Value
$36.60K
Shares Held After
1,490,745
% of Holdings
4.6%
Keros Therapeutics, Inc. (KROS)
Seehra Jasbir — Director
Shares
7,015
Price
$16.17
Total Value
$113.43K
Shares Held After
385,708
% of Holdings
1.8%
Aveanna Healthcare Holdings, Inc. (AVAH)
Shaner Jeff — Chief Executive Officer
Shares
173,225
Price
$7.21
Total Value
$1.25M
Shares Held After
2,650,892
% of Holdings
6.1%
Aveanna Healthcare Holdings, Inc. (AVAH)
Buckhalter Matthew — Chief Financial Officer
Shares
13,512
Price
$7.21
Total Value
$97.40K
Shares Held After
529,243
% of Holdings
2.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
Cunningham Patrick A. — Chief Compliance Officer
Shares
18,436
Price
$7.21
Total Value
$132.89K
Shares Held After
337,755
% of Holdings
5.2%
Aveanna Healthcare Holdings, Inc. (AVAH)
Stewart Deborah — SVP, Chief Accounting Officer
Shares
11,181
Price
$7.21
Total Value
$80.59K
Shares Held After
301,807
% of Holdings
3.6%
Aveanna Healthcare Holdings, Inc. (AVAH)
Reisz Edwin C. — Chief Administrative Officer
Shares
60,769
Price
$7.21
Total Value
$438.04K
Shares Held After
1,447,057
% of Holdings
4.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
585
Price
$103.28
Total Value
$60.42K
Shares Held After
110,512
% of Holdings
0.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
800
Price
$102.10
Total Value
$81.68K
Shares Held After
111,097
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,692
Price
$100.92
Total Value
$170.75K
Shares Held After
111,897
% of Holdings
1.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,308
Price
$100.27
Total Value
$131.15K
Shares Held After
113,589
% of Holdings
1.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.46
Total Value
$138.40K
Shares Held After
906,556
% of Holdings
4.2%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
100
Price
$69.38
Total Value
$6.94K
Shares Held After
45,157
% of Holdings
0.2%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
5,405
Price
$68.57
Total Value
$370.63K
Shares Held After
45,257
% of Holdings
10.7%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
2,879
Price
$67.73
Total Value
$194.99K
Shares Held After
50,662
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,467
Price
$478.92
Total Value
$702.57K
Shares Held After
36,781
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,100
Price
$478.15
Total Value
$1.00M
Shares Held After
38,248
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,114
Price
$477.10
Total Value
$531.48K
Shares Held After
40,348
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
881
Price
$475.89
Total Value
$419.26K
Shares Held After
41,462
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,059
Price
$475.09
Total Value
$503.12K
Shares Held After
42,343
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
288
Price
$473.23
Total Value
$136.29K
Shares Held After
43,402
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
775
Price
$472.76
Total Value
$366.39K
Shares Held After
43,690
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
616
Price
$471.36
Total Value
$290.36K
Shares Held After
44,465
% of Holdings
1.4%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
1,200
Price
$9.60
Total Value
$11.52K
Shares Held After
259,992
% of Holdings
0.5%
PULSE BIOSCIENCES, INC. (PLSE)
Danahy Kevin Patrick — Chief Commercial Officer
Shares
5,000
Price
$23.64
Total Value
$118.20K
Shares Held After
43,298
% of Holdings
10.4%
EXELIXIS, INC. (EXEL)
WYSZOMIERSKI JACK L — Director
Shares
99,574
Price
$44.01
Total Value
$4.38M
Shares Held After
279,942
% of Holdings
26.2%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
423
Price
$73.00
Total Value
$30.88K
Shares Held After
75,489
% of Holdings
0.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
180
Price
$73.00
Total Value
$13.14K
Shares Held After
21,174
% of Holdings
0.8%
ALIGN TECHNOLOGY INC (ALGN)
Morici John — EVP, CHIEF FINANCIAL OFFICER
Shares
7,969
Price
$189.31
Total Value
$1.51M
Shares Held After
8,237
% of Holdings
49.2%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
10,658
Price
$17.48
Total Value
$186.30K
Shares Held After
10,658
% of Holdings
100.0%
PTC THERAPEUTICS, INC. (PTCT)
Gravier Pierre — CHIEF FINANCIAL OFFICER
Shares
2,992
Price
$69.36
Total Value
$207.53K
Shares Held After
87,318
% of Holdings
3.3%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
2,484
Price
$69.36
Total Value
$172.29K
Shares Held After
89,944
% of Holdings
2.7%
Showing 501–550 of 1586 transactions (page 11 of 32)